Payment overview · 2025
General Payments
$15.64
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mark A Olson, MD
Allopathic & Osteopathic Physicians|Family Medicine · WILLISTON, ND · NPI 1023182110
Verified facts
What the public records show
CMS Open Payments records show Mark A Olson, MD received $15.64 in general payments during 2025 across 1 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$15.64 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.64 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $15.64 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 609 | 163 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 413 | 103 |
| Losartan Potassium | Losartan Potassium | 372 | 100 |
| Omeprazole | Omeprazole | 365 | 78 |
| Levothyroxine Sodium | Levothyroxine Sodium | 361 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 355 | 87 |
| Lisinopril | Lisinopril | 284 | 66 |
| Furosemide | Furosemide | 273 | 66 |
| Hydrochlorothiazide | Hydrochlorothiazide | 270 | 70 |
| Potassium Chloride | Potassium Chloride | 258 | 72 |
| Amlodipine Besylate | Amlodipine Besylate | 231 | 62 |
| Metformin Hcl | Metformin Hcl | 212 | 52 |
| Lorazepam | Lorazepam | 171 | 34 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 166 | 45 |
| Bupropion Xl | Bupropion Hcl | 135 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 135 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 29 |
| Eliquis | Apixaban | 127 | 23 |
| Tamsulosin Hcl | Tamsulosin Hcl | 126 | 38 |
| Pioglitazone Hcl | Pioglitazone Hcl | 117 | 32 |
| Sertraline Hcl | Sertraline Hcl | 116 | 33 |
| Simvastatin | Simvastatin | 106 | 28 |
| Jardiance | Empagliflozin | 104 | 15 |
| Atenolol | Atenolol | 102 | 22 |
| Pregabalin | Pregabalin | 102 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 100 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 96 | 35 |
| Pravastatin Sodium | Pravastatin Sodium | 91 | 19 |
| Gabapentin | Gabapentin | 90 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 87 | 16 |
| Celecoxib | Celecoxib | 86 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 83 | 26 |
| Meloxicam | Meloxicam | 81 | 25 |
| Allopurinol | Allopurinol | 74 | 22 |
| Doxazosin Mesylate | Doxazosin Mesylate | 74 | 17 |
| Metformin Hcl Er | Metformin Hcl | 73 | 22 |
| Breo Ellipta | Fluticasone/Vilanterol | 72 | 11 |
| Famotidine | Famotidine | 72 | 18 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 70 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 67 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 66 | 20 |
| Xarelto | Rivaroxaban | 66 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 65 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 63 | 22 |
| Mirtazapine | Mirtazapine | 58 | 14 |
| Prednisone | Prednisone | 58 | 37 |
| Finasteride | Finasteride | 56 | 15 |
| Tramadol Hcl | Tramadol Hcl | 54 | 14 |
| Ezetimibe | Ezetimibe | 53 | 18 |
| Warfarin Sodium | Warfarin Sodium | 53 | suppressed |
| Carvedilol | Carvedilol | 52 | 17 |
| Spironolactone | Spironolactone | 52 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 51 | 13 |
| Alprazolam | Alprazolam | 49 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 49 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 48 | 13 |
| Glimepiride | Glimepiride | 48 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 48 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 47 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 46 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 45 | suppressed |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 44 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 42 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 42 | 20 |
| Farxiga | Dapagliflozin Propanediol | 41 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 41 | suppressed |
| Gemfibrozil | Gemfibrozil | 40 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 40 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 38 | suppressed |
| Oxycontin | Oxycodone Hcl | 36 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | suppressed |
| Levetiracetam | Levetiracetam | 34 | suppressed |
| Chlorthalidone | Chlorthalidone | 33 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 32 | 11 |
| Ozempic | Semaglutide | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 19 |
| Clonazepam | Clonazepam | 26 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Olanzapine | Olanzapine | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 22 |
| Synthroid | Levothyroxine Sodium | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Dutasteride | Dutasteride | 23 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 23 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 22 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Amoxicillin | Amoxicillin | 21 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 21 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Azithromycin | Azithromycin | 20 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 16 |
| Diltiazem 24hr Er | Diltiazem Hcl | 20 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 20 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Mounjaro | Tirzepatide | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 14 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Fluconazole | Fluconazole | 16 | 12 |
| Trulicity | Dulaglutide | 16 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Tymlos | Abaloparatide | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Rebif | Interferon Beta-1a/Albumin | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Cefdinir | Cefdinir | 12 | 12 |
| Glipizide Er | Glipizide | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.64 · 1 records | Medtronic, Inc. | MINIMED 780G | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error